Related Experiment Videos
Chlamydia pneumoniae resists antibiotics in lymphocytes
Hiroyuki Yamaguchi1, Herman Friedman, Mayumi Yamamoto
1Department of Medical Microbiology and Immunology, College of Medicine, University of South Florida, Tampa, Florida 33612, USA.
Antimicrobial Agents and Chemotherapy
|May 23, 2003
Summary
Antibiotic effectiveness against Chlamydia pneumoniae in lymphocytes is lower than in epithelial cells. Controlling this bacterium in lymphocytes is crucial for preventing chronic inflammatory diseases.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Chlamydia pneumoniae infection of lymphocytes is linked to chronic inflammatory diseases.
- Controlling C. pneumoniae in lymphocytes is critical for disease management.
Purpose of the Study:
- To assess antibiotic activity against Chlamydia pneumoniae within lymphocytes.
- To compare antibiotic efficacy in lymphocytes versus epithelial cells.
Main Methods:
- An in vitro infection model using lymphoid cells was employed.
- Antibiotic activity was evaluated against C. pneumoniae in lymphocytes and epithelial cells.
Main Results:
- All tested antibiotics showed high activity against C. pneumoniae in epithelial cells.
- C. pneumoniae in lymphocytes demonstrated reduced susceptibility to antibiotics compared to epithelial cells.
Conclusions:
- Lymphocytes are a less effective environment for antibiotic treatment of C. pneumoniae.
- Standard antibiotic evaluations using epithelial cells may not fully represent in vivo efficacy in lymphoid tissues.